tetano
Editor, Senior Moderator
World J Virol
. 2022 Nov 25;11(6):453-466.
doi: 10.5501/wjv.v11.i6.453.
Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective
Farina M Hanif[SUP] 1 [/SUP], Zain Majid[SUP] 1 [/SUP], Shoaib Ahmed[SUP] 1 [/SUP], Nasir H Luck[SUP] 1 [/SUP], Muhammed Mubarak[SUP] 2 [/SUP]
Affiliations
Abstract
The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has become a global challenge of unprecedented nature since December 2019. Although most patients with COVID-19 exhibit mild clinical manifestations and upper respiratory tract involvement, in approximately 5%-10% of patients, the disease is severe and involves multiple organs, leading to multi-organ dysfunction and failure. The liver and gastrointestinal tract are also frequently involved in COVID-19. In the context of liver involvement in patients with COVID-19, many key aspects need to be addressed in both native and transplanted organs. This review focuses on the clinical presentations and laboratory abnormalities of liver function tests in patients with COVID-19 with no prior liver disease, patients with pre-existing liver diseases and liver transplant recipients. A brief overview of the history of COVID-19 and etiopathogenesis of the liver injury will also be described as a prelude to better understanding the above aspects.
Keywords: COVID-19; Cirrhosis; Clinical manifestations; Liver function tests; Liver injury; SARS-CoV-2.
. 2022 Nov 25;11(6):453-466.
doi: 10.5501/wjv.v11.i6.453.
Hepatic manifestations of coronavirus disease 2019 infection: Clinical and laboratory perspective
Farina M Hanif[SUP] 1 [/SUP], Zain Majid[SUP] 1 [/SUP], Shoaib Ahmed[SUP] 1 [/SUP], Nasir H Luck[SUP] 1 [/SUP], Muhammed Mubarak[SUP] 2 [/SUP]
Affiliations
- PMID: 36483109
- PMCID: PMC9724207
- DOI: 10.5501/wjv.v11.i6.453
Abstract
The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has become a global challenge of unprecedented nature since December 2019. Although most patients with COVID-19 exhibit mild clinical manifestations and upper respiratory tract involvement, in approximately 5%-10% of patients, the disease is severe and involves multiple organs, leading to multi-organ dysfunction and failure. The liver and gastrointestinal tract are also frequently involved in COVID-19. In the context of liver involvement in patients with COVID-19, many key aspects need to be addressed in both native and transplanted organs. This review focuses on the clinical presentations and laboratory abnormalities of liver function tests in patients with COVID-19 with no prior liver disease, patients with pre-existing liver diseases and liver transplant recipients. A brief overview of the history of COVID-19 and etiopathogenesis of the liver injury will also be described as a prelude to better understanding the above aspects.
Keywords: COVID-19; Cirrhosis; Clinical manifestations; Liver function tests; Liver injury; SARS-CoV-2.